git kurdistan board geh j club: hcc biomarkers
TRANSCRIPT
![Page 1: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/1.jpg)
![Page 2: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/2.jpg)
Introduction:• Cancer biomarkers are molecules or
substances measurable in cel ls , tissues,
or body fluids that indicate presence or
predict the risk of cancer development.
• Cancer biomarkers are proteins in serum
or plasma.
• Recent advances al lowed discovery of
novel HCC biomarkers, including DNA-fusion
genes, genetic mutations , epigenetic
changes, messenger RNA, (miRNAs), other
species, proteins& posttranslational
protein modifications (eg, phosphorylation),
metabol ites, & antibodies.
• These may be detectable in whole blood,
white blood cel ls , serum, plasma, urine,
normal tissue (eg, buccal mucosa), tumor
tissue, or adjacent benign l iver tissue.
![Page 3: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/3.jpg)
Introduction:• The serum a -fetoprotein (AFP) has been
the most commonly used HCC biomarker,
functioning as a risk assessment tool in
patients with cirrhosis, as a screening
tool for early HCC detection, as a
diagnostic tool&as a prognostic tool for
tumor recurrence or patient survival .
• More recently, the scope of appl ications
for HCC biomarkers has expanded beyond
diagnostic and survei l lance/ screening
purposes.
• HCC biomarkers can be used to identify
at-risk populations, stratify patients for
cl in ical trials, tai lor therapy,&predict
treatment response.
![Page 4: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/4.jpg)
![Page 5: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/5.jpg)
![Page 6: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/6.jpg)
![Page 7: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/7.jpg)
![Page 8: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/8.jpg)
![Page 9: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/9.jpg)
![Page 10: GIT Kurdistan board GEH J Club: HCC biomarkers](https://reader030.vdocument.in/reader030/viewer/2022032420/55a603cc1a28abe20b8b4584/html5/thumbnails/10.jpg)